PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Creation of a new molecule through innovative combination of two reactions

Building up new macrocyclic molecules using both dynamic covalent and coordination reactions

Creation of a new molecule through innovative combination of two reactions
2023-06-13
(Press-News.org)

A research group led by Professor Hideki Fujiwara and Associate Professor Daisuke Sakamaki from the Graduate School of Science at Osaka Metropolitan University succeeded, for the first time, in synthesizing a new molecule using a novel combination of dynamic covalent chemistry, in which organic radicals couple and dissociate reversibly, and coordination chemistry, which binds radicals to metal ligands. The study shows that the two types of reactions work without inhibiting each other.

“This research was based on a very simple idea of combining two types of reactions,” stated Professor Sakamaki. “However, it was not clear if these reactions could coexist because they are so different in nature. Our results are expected to contribute to the development of new synthetic components for functional materials, such as sensing materials and porous materials.”

The study findings were published in Angewandte Chemie International Edition.

###

About OMU 

Osaka Metropolitan University is the third largest public university in Japan, formed by a merger between Osaka City University and Osaka Prefecture University in 2022. OMU upholds "Convergence of Knowledge" through 11 undergraduate schools, a college, and 15 graduate schools. For more research news visit https://www.omu.ac.jp/en/ or follow us on Twitter: @OsakaMetUniv_en, or Facebook. 

END


[Attachments] See images for this press release:
Creation of a new molecule through innovative combination of two reactions Creation of a new molecule through innovative combination of two reactions 2

ELSE PRESS RELEASES FROM THIS DATE:

Elevated Lipoprotein(a) is the latest variant of ‘bad cholesterol’ found to increase the risk of recurrent coronary heart disease

2023-06-13
Increased levels of Lipoprotein(a), a variant of ‘bad cholesterol’, in the bloodstream are a risk factor for recurrent coronary heart disease (CHD) in people aged 60 or over, according to the results of a new study which tracked the issue over the course of 16 years. The results, published today in Current Medical Research & Opinion, suggest that current cholesterol-lowering medications may not be effective at reducing the risk of recurrent CHD – such as a heart attack – due to elevated Lp(a). “This finding adds to growing evidence of a relationship between increased Lp(a) and the risk of recurrent CHD,” says lead author Associate Professor ...

USTC achieves breakthrough in in-situ detection of gas-phase active intermediates in photocatalysis

USTC achieves breakthrough in in-situ detection of gas-phase active intermediates in photocatalysis
2023-06-13
Prof. PAN Yang and Associate Researcher LIU Chengyuan, researchers from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences (CAS), have achieved significant progress in detecting intermediates in methane photocatalytic reactions. Their technique, Synchronous Radiation Photoionization Mass Spectrometry (SR-PIMS), allows for in-situ detection of active intermediates. The findings were published in the prestigious chemistry journal Angewandte Chemie International ...

USTC provides comprehensive review of quantum teleportation in Nature Review Physics

USTC provides comprehensive review of quantum teleportation in Nature Review Physics
2023-06-13
A team led by Academician Prof. GUO Guangcan from the Chinese Academy of Sciences (CAS) provides a comprehensive overview of the progress achieved in the field of quantum teleportation. The team, which includes Prof. HU Xiaomin, Prof. GUO Yu, Prof. LIU Biheng, and Prof. LI Chuanfeng from the University of Science and Technology of China (USTC),CAS, was invited to publish a review paper on quantum teleportation in Nature Review Physics. The paper was officially released online on May 24.   As one of the most important protocols in the field ...

USTC achieves thousand-kilometer quantum key distribution

USTC achieves thousand-kilometer quantum key distribution
2023-06-13
A point-to-point long-distance quantum key distribution (QKD) over a distance of 1,002 km has been achieved by scientists from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences (CAS), and their collaborators from Tsinghua University, Jinan Institute of Quantum Technology, and Shanghai Institute of Microsystem and Information Technology (SIMIT), CAS. This milestone not only sets a new world record for non-relay QKD but also provides a solution for high-speed intercity quantum communication. The ...

ASHP Summer Meeting Tip Sheet

2023-06-13
Posters All poster presentations will take place on Monday, June 12, 2023, from 12:15 to 1:30 p.m. EDT, or Tuesday, June 13, 2023, from 12:15 to 1:30 p.m. EDT at the Baltimore Convention Center, Exhibit Hall E, Level 100.   Abstract 4-M (Monday) Avoiding Clinical Inertia: Comparing Time to Intensification of Glucagon-like peptide-1 (GLP-1) Receptor Agonists in Patients with Type 2 Diabetes Mellitus Among Clinical Pharmacists versus Providers Clinical pharmacists have a significant impact on medication optimization and reduction ...

MOVA: new method for evaluating the pathogenicity of missense variants using AlphaFold2

MOVA: new method for evaluating the pathogenicity of missense variants using AlphaFold2
2023-06-13
Niigata, Japan - The Department of Neurology at Niigata University has developed a new in silico method for evaluating the pathogenicity of missense variants using AlphaFold2 (MOVA). Rare variants in the causative gene of ALS are present in 10-30% of sporadic ALS cases, which highlights the need for accurate and efficient pathogenicity prediction methods. To predict the pathogenicity of the variants, in silico analysis methods are commonly used. In some ALS causal genes, the mutations are concentrated in specific regions, and the accuracy of pathogenicity prediction can be improved by considering the positional information of the variants. ...

23Na MRI technique unleashes new approach for diagnosing diabetic kidney disease

23Na MRI technique unleashes new approach for diagnosing diabetic kidney disease
2023-06-13
Niigata, Japan - The gold standard test for predicting the onset of diabetic kidney disease is albuminuria. However, detecting albuminuria alone has limited sensitivity and specificity in end-stage renal failure with a decreased estimated glomerular filtration rate. This is supported by several reports, which state that about half of the type 2 diabetes patients who developed kidney dysfunction showed no preceding albuminuria. In this study, the authors propose the possibility of diagnosing tubular abnormalities in diabetic kidney disease at an early stage and connecting them to treatment by combining the evaluation of sodium concentration using 23Na MRI ...

Immune cell movement worse in older females, mice study finds

2023-06-13
Older female mice had more immune cells entering areas of the body where they shouldn’t according to a new study, demonstrating that sex differences contribute to age-related inflammation that needs to be considered in future research.   In a paper published in Journal of Leukocyte Biology today (Tuesday 13 June), at team of researchers led by Dr Myriam Chimen from the University of Birmingham have found that age significantly increases the number of immune cells entering the sack that holds major organs (peritoneal cavity) in female mice, when compared to young mice or older male mice.   The findings support previous studies that suggest ...

THE LANCET: First phase 3 trial of a chikungunya vaccine candidate finds it is generally safe and provokes an immune response

2023-06-13
Peer-reviewed / Randomised Controlled Trial / People Study of healthy US adults found that a single dose of the VLA1553 vaccine candidate was generally safe, well tolerated and provokes an immune response. After a single vaccination, the vaccine produced neutralizing antibody levels which are thought to protect against chikungunya disease in 99% (263/266) of participants. Antibody levels declined 28 days after vaccination, but seroprotection persisted in more than 96% (233/242) participants after six months. Most adverse events were moderate or mild and the authors say its safety profile is similar to other licensed vaccines The VLA1553 vaccine candidate ...

The chatbot will see you now:

2023-06-13
Glasgow, UK:  The informed consent process in biomedical research is biased towards people who can meet with clinical study staff during the working day. For those who have the availability to have a consent conversation, the time burden can be off-putting. Professor Eric Vilain, from the Department of Paediatrics, University of California, Irvine, USA, will tell the European Society of Human Genetics annual conference today (Tuesday 13 June) how results from his team’s study of the use of a chatbot (GIA – ‘Genetics Information Assistant’ ...

LAST 30 PRESS RELEASES:

Science briefing: An update on GLP-1 drugs for obesity

Lower doses of immunotherapy for skin cancer give better results

Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A sound defense: Noisy pupae puff away potential predators

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

[Press-News.org] Creation of a new molecule through innovative combination of two reactions
Building up new macrocyclic molecules using both dynamic covalent and coordination reactions